Taspoglutide
Taspoglutide is a pharmaceutical drug, a glucagon-like peptide-1 agonist (GLP-1 agonist), under investigation for treatment of type 2 diabetes being codeveloped by Ipsen and Roche.
| Catalog Number | 10-101-176 |
| Alternative Name(s) | UNII-2PHK27IP3B |
| Research Area | Taspoglutide is developed for treatment of type 2 diabetes |
| Molecular Formula | C152H232N40O45 |
| CAS# | 275371-94-3 |
| Purity | >95% |
| Size | Inquiry |
| Supplier Page | https://www.creative-peptides.com/product/taspoglutide-item-10-101-176-33662.html |